We’re thrilled that Animas/J&J has joined Dexcom, Insulet/OmniPod, Tandem and Abbott in making data from their devices available through the Tidepool Platform. In this guest blog post, John Wilson, WW VP of Insulin Delivery at Johnson & Johnson Diabetes Solutions, shares the news. Thanks to John and everyone at Animas/J&J! — Howard
Dive In! Animas + Tidepool
John Wilson, WW Vice President of Insulin Delivery
Johnson & Johnson Diabetes Solutions Companies
Animas® pump users will be able to dive – or wade if they rather – into Tidepool!
I am thrilled to announce a new partnership between Animas and Tidepool. Our collaboration is about doing the right thing for people with diabetes by giving them control over their own pump data and the ability to choose who sees it, as well as the tools and devices they use to manage it. By assisting in opening this door to better communication between patients, caregivers, physicians, and industry, we aim to influence better care and progress for the future.
Johnson & Johnson Diabetes Solutions Companies is focused on providing support, education, and products that address the unmet needs in the diabetes community. We strongly believe that Tidepool’s open-source software will further support patients’ ability to make better, more well-informed “throughout-the-day” decisions related to diabetes management and treatment. After all, a one-size- fits-all approach rarely works in any scenario, and it certainly doesn’t work for diabetes management.
I am personally very excited about this partnership as a step forward in breaking down barriers in diabetes management and providing valuable data to fuel advancements on the horizon. The strong sense of community and passion in the DOC and broader community has truly inspired me since joining the team, and I cannot wait to see what connections we will make together next.
People living with diabetes face into the challenge every single day and they deserve to have the ability to effectively utilize data to help them manage it. I believe that collaborations like this one enable us to bring meaningful innovations to those who need them today, while we continue to work collectively towards more solutions – and ultimately a cure – for this inordinately burdensome disease.
August 4th, 2015
(Official press release.)
We’re thrilled to announce that The Leona M. and Harry B. Helmsley Charitable Trust has awarded a $900,000 grant to Tidepool to support continued development of the Tidepool Platform and Tidepool Uploader. All by itself, this is an incredibly generous and wonderful statement of support of Tidepool’s efforts to make diabetes data more accessible to people with diabetes, their caregivers and diabetes researchers.
But wait, there’s more. As part of this grant, the Helmsley Charitable Trust is offering a $300,000 matching challenge grant, meaning that the Helmsley Charitable Trust will DOUBLE the impact of your donations to Tidepool. There has never been a better time to support Tidepool’s efforts. As a matter of fact, there’s no time like the present, so please visit tidepool.org/donate and donate now, or send us an email if you’d like to donate securities or talk more.
As you probably know, the Helmsley Charitable Trust is the largest private foundation funder of T1D-related research, treatment and support services in the nation. With this grant, the Trust is enabling us to further expand the Tidepool Platform and provide APIs that will enable developers to write applications that securely access diabetes data (using Oauth2 and REST APIs, for the nerds among us). The possibilities are endless – we see a vibrant ecosystem of applications that can share diabetes data with the user’s permission.
A huge impediment to diabetes research is access to high-quality, correlated device data. This grant also enables us to expand our research APIs and query interfaces. We will also offer all Tidepool users the opportunity to donate their data to the T1D Exchange and Jaeb Center for Health Research, two of the largest and most respected T1D research organizations, also funded by the Helmsley Charitable Trust. (As always, we firmly believe that patients own their own health data, so donating data is a CHOICE we will offer and enable, and is not at all a requirement.)
Finally, this grant enables us to continue to add new devices to the Tidepool Uploader, further expanding the number of devices we are able to read data from. As we’ve previously said, the Tidepool Uploader will support devices from Asante, Dexcom, Insulet/OmniPod, Tandem/t:slim, and Abbott. This grant will allow us to add more blood glucose meters and insulin pumps as device makers make their protocols available.
And to answer the question on everyone’s mind: So when can I get access to all of this? We’re currently in the thick of a private beta of both Blip and the Tidepool Uploader. We are also currently supporting the “Replace BG” study being conducted at the Jaeb Center (and also supported by the Helmsley Charitable Trust). We expect to be expanding to a public Beta over the next couple of months and hope to release the Tidepool Uploader, Blip and our developer interfaces shortly after that.
We simply cannot be more thankful to our friends at the Helmsley Charitable Trust who have shown over the years an incredible dedication to supporting research and better treatments for people living with type 1 diabetes. With this generous grant, the Helmsley Charitable Trust enables Tidepool to help accelerate development of our platform, enable an ecosystem of diabetes apps and research, and to bring even more devices on board.
And best of all, by offering a matching grant, they are doubling the impact that you can have. Won’t you please join us? Please visit tidepool.org/donate to donate now.
April 27th, 2015
This is a big day for Tidepool and for the diabetes community. In addition to partnering with JDRF, we are thrilled to announce that Insulet has given us their data protocol specification, and that we are actively incorporating OmniPod support into the Tidepool Platform. The question is no longer “Which device maker will be next?” to embrace patient access to data, it’s “Which device maker will be last?” In this guest post, Raul Oliva, Director of Marketing for Insulet, lets us know why this is so important. Cheers, Howard
Insulet and Tidepool
Raul Oliva, Marketing Director at Insulet
Insulet is pleased to announce we are opening our data protocol to Tidepool to enable OmniPod users to upload their insulin pump and integrated blood glucose meter data to the Tidepool platform and future Tidepool applications. With the announcement from Dexcom regarding their agreement with Tidepool in August, users of both OmniPod insulin pumps and Dexcom continuous glucose monitors will see their data from both devices in one place in future Tidepool applications.
Every day, people with diabetes and their loved ones process tremendous amounts of data across many variables that can affect blood sugar to make so many decisions throughout the day. It can be an overwhelming under-taking that is never-ending; so overwhelming, in fact, that many people give up or choose to ignore their data, often relying on “gut” decisions.
Insulet believes that software will make critical data intuitive, actionable, and ultimately reduce the burden of managing diabetes. But, the devices are as diverse as the data; insulin pump data from the OmniPod, CGM data from Dexcom G4 Platinum, BG data from the meter, carb data from a carb app, and activity data from a wearable device, to name a few. We are excited about the first step to bring this data together in one place to provide actionable insights that will help people review their or their loved one’s data, optimize their care, and continue to make better decisions about their diabetes.
At Insulet, we are committed to making diabetes a smaller part of life; to make it easier for people living or living with someone with diabetes. We continue to innovate in the world of insulin pump technology to improve the delivery of insulin and help more patients realize the benefits of insulin pump therapy when they may have thought a pump was “too much” for them. Our hope is that through opening up our data protocol to Tidepool, we will enable others to innovate in the world of diabetes data and develop easy-to-use solutions that provide actionable insights to all people affected by diabetes.
September 16th, 2014
We’re so excited about this guest post from Dexcom CTO Jorge Valdes. By joining the Tidepool platform, Dexcom is now the second device maker (Asante was the first) to say loud and clear: You own your data, and you should be able to use the app that’s right for you to help you manage your diabetes. We look forward to more soon. Cheers, Howard
It’s Official: Dexcom + Tidepool!
Jorge Valdes, CTO, Dexcom
Dexcom is very pleased to announce that we have entered into an agreement with Tidepool to license the G4 Platinum data protocol. This means that all Tidepool applications will be able to read data from the Dexcom G4 Platinum receiver. The collaboration provides patients with greater access to their data and improves their ability to manage their disease.
Dexcom strongly believes that the best way to help patients is to provide an open interface to access their data. Dexcom will always continue to provide industry leading CGM solutions and simple to use interfaces for patients on our receivers and smartphone apps, but we realize that it is not practical for us to attempt to provide every possible solution and feature for patients. That is why having an open interface and teaming with companies such as Tidepool is the best way to help patients. Together, Dexcom and its officially licensed partners can bring a suite of solutions to help patients manage their diabetes, greater than what any company can do on its own. We envision software such as data visualization tools, data analysis tools, food journals, broader tools that look at additional health factors, and electronic medical records. Assisting patients to share their data is the best way to help them manage their disease.
We look forward to a successful relationship with Tidepool and their excellent suite of apps!
August 6th, 2014
We’re really excited about this guest post from Asante’s CEO, David Thrower. Kudos to Asante for their support of patient access to data and setting a great example for other diabetes device makers. Cheers, Howard
The Data is Yours
David Thrower, CEO, Asante Solutions
When we founded Asante Solutions, we wanted to base it on more than a pump. So we founded it on a promise. A promise to make life simpler for people with diabetes, and those who love them. This promise of simplicity began with the launch of the Snap Insulin Pump and it will go much further in the future. One important and unique part of our promise is making your data available for you to use, wherever and whenever you want.
When you use the Snap pump, you are capturing a lot of data on your insulin dosing, your carbohydrate intake, and your blood sugar levels. We make that all available to you on the logbook so you can see it all anytime. We know, however, that there are so many more ways that you could use your data. You just need a way for your pump to talk to other devices.
That is why we were so happy to see Tidepool at the 2013 DiabetesMine Innovation Summit. Their presentation was very compelling and we knew we wanted to work with them. One of their core beliefs really rings very true: “People with diabetes live in a sea of unused data generated by devices that don’t talk to each other. This is insane,” their CEO, Howard Look, told us. I could not have said it any better myself. The challenge for Asante, however, is “how do we make the Snap pump talk to all the other devices when we only make the pump?”
That is where Tidepool comes in. Their commitment to an open platform is refreshing and needed. The data in your pump is yours, not a pump company’s. We did not want to create a proprietary system with a communication protocol known only to Asante and that could be used only with devices and apps that we chose – the choice should be yours.
Because of our belief and the fantastic work that Tidepool is doing, we are happy to announce Asante’s partnership with Tidepool. We are honored to be the first insulin pump to make our protocols available to Tidepool. What that means is we have given Tidepool the information that they need to take the data in Snap and place it into their open data platform. Tidepool has more work to do before this is available, but we are very excited about the future. Once Snap users can get the data from the Snap Insulin Pump into the Tidepool platform, they can then use their data to fuel other apps and dashboards. Imagine an app that uses your CGM data and the data from your Snap Insulin Pump to recommend a change to your typical breakfast that could better keep your morning BG in control. Isn’t that the kind of integration that will make the management of diabetes simpler? That is just one example of the hundreds of ways that we believe our partnership with Tidepool will help make your life a little easier. In the end, that is our promise to those that use our pump. It is also the commitment of Tidepool. After all, the data is yours…
CEO of Asante Solutions
January 27th, 2014
Happy New Year!
Back when we founded Tidepool (originally named “GreenDot Diabetes”), we made two important decisions:
1) We would be an open source effort, and
2) We would be non-profit.
These were not decisions we took lightly. Most of us live in the SF Bay Area, in the heart of the very much for-profit Silicon Valley and near venture capital mecca, Sand Hill Road.
Quite simply, we chose to be open and non-profit because it’s the best way for us to make a difference for people with diabetes. We are here to help the industry make a great leap forward. We think we are building a platform and great apps that can help everyone with diabetes, and being open and non-profit allows us to “do the right thing” and help the industry as a whole in a non-competitive way.
We were very fortunate to have very generous donors in 2013 who believe in us and our plan. That “seed round” (using Silicon Valley terms) of philanthropy allowed us to hire a phenomenal team passionate about helping the world of diabetes technology. Seven of the 11 Tidepoolers have Type 1 Diabetes, and two of us have family members with T1D.
We recently kicked off our “A round” fundraising efforts for 2014. Because we are open and non-profit we are happy that we can be transparent about our plans and ask for your help in making them better.
Our 2013 $1.5M “seed round” will last us through the end of April. 2014. For our “A Round” of philanthropy, we are seeking $3M, which will carry us into 2015 while we continue to build out our platform and applications that accelerate progress towards cloud-connected, closed-loop systems. We will likely need one more funding round in 2015, which will then take us to the point where we can generate modest revenue and become a self-sustaining non-profit.
Here’s how you can help us be successful with our fundraising plans:
If you are a “Githubber”, you can find our Helmsley Charitable Trust draft application here. Feel free to comment using issues, or fork the markdown and submit a pull request.
If you have a Google account, you can comment on the draft documents here.
If you have friends at the Helmsley Charitable Trust, JDRF or the Robert Wood Johnson Foundation, tell them the difference we are making and encourage them to put in a good word for us!
If you have friends with a connection to T1D who you think might like to support Tidepool’s efforts, please put them in touch with us.
And of course, if you’d like to help personally, we’d welcome that, too! We applied for 501c3 status (read our application here) back in June, 2013 and are still waiting for a decision from the IRS. Having broad financial support from the diabetes community, at any level, is very helpful to the cause. Thanks in advance!
For 2014, we’re really looking forward to building on the great progress and momentum we generated in 2013 (check out some of the great blog posts below). Thanks again for all of your support!
JDRF's Jiangfeng Fei via DiabetesMine “JDRF: Patient Needs Must Drive T1 Diabetes Innovation” Dec 9, 2013.
Mike Hoskins at DiabetesMine.com “Wanted in a Nutshell: Hassle-Free Diabetes Tech,” . Dec 6, 2013.
Christel at ThePerfectD.com “Swept Away by Tidepool,” Dec 5, 2013.
Wil Dubois at DiabetesMine.com “A Skeptic’s View of Our Summit: Anger and Hope in Palo Alto,” Dec 3, 2013.
Steve Blank “When Customers Make You Smarter,” Dec 2, 2013.
John Walsh and Ruth Roberts at Diabetesnet.com “Tidepool – Acquiring, Storing, and Opening Data for Improved Diabetes Care”
Amy Tendrich at DiabetesMine.com “The making of a D-Tech Startup: Tidepool’s Universal Data Platform,” May 28, 2013.
Also check out these videos from our “Lean Launchpad for Healthcare” final presentation at UCSF:
January 7th, 2014
Diabetes Mine's editor-in-chief Amy Tendrich wanted to find out more about Tidepool and she got the inside story.
Amy and I got in contact a few months ago after I heard about their DiabetesMine Innovation Summit, and saw their video calling for D-data standardization and an open model of diabetes care.
I invited Amy to come to San Francisco and to join us at a planning session. She got to meet the team and listen in as we worked through a long startup agenda. We also gave her a demo of blip, the first application that sits on top of Tidepool‘s platform. blip provides intuitive, interactive visualizations of data from multiple sources, including insulin pumps, CGMs and activity monitors.
Amy's take on Tidepool: "They were speaking my language!"
Check out the story.
June 14th, 2013